"For Research Use Only" (RUO) appears on reagents, instruments, antibodies, standards and research peptides. It is printed so often that it can look like boilerplate. It isn't. The phrase has a specific origin in US regulation, and the US Food and Drug Administration (FDA) has said plainly that the label on its own doesn't decide how a product is regulated. What a supplier says and does around the product matters as much as the words on the vial.
This guide explains where the RUO phrase comes from, what FDA's published guidance says about it, and what "research use only" should mean in practice for the companies that sell RUO materials and the laboratories that buy them.
This article is general information, not legal advice. If you need a ruling on a specific product or situation, ask a qualified regulatory lawyer.
Where the phrase comes from
The exact wording traces to FDA's labeling regulation for in vitro diagnostic (IVD) products, 21 CFR 809.10. Paragraph (c)(2)(i) says that a product "in the laboratory research phase of development, and not represented as an effective in vitro diagnostic product" must carry, prominently placed on all labeling, the statement:
"For Research Use Only. Not for use in diagnostic procedures."
(21 CFR 809.10(c)(2)(i), eCFR, current as of 25 September 2026)
The same paragraph sets out a sister label, "For Investigational Use Only," for products in a later product-testing phase.
So the phrase was written for a particular category: diagnostic products still in the lab. Over time "research use only" has become the general way the research-supply industry marks materials intended for laboratory work rather than any other purpose. Research peptides sit in that broader usage. The regulation is still the best guide to what the words are meant to signal.
What FDA says the label does, and doesn't, do
In 2013 FDA published guidance on distributing IVD products labeled RUO or IUO (FDA, Distribution of In Vitro Diagnostic Products Labeled for Research Use Only or Investigational Use Only, November 2013). The guidance is about diagnostic products specifically, and FDA notes that guidance documents are recommendations, not binding rules. But its reasoning is the clearest public statement of how FDA thinks about the RUO label, and three points from it apply broadly.
1. The label is a warning
FDA describes RUO labeling as "meant to serve as a warning," intended to prevent products from being used outside research.
2. The label alone doesn't decide anything
The guidance says: "Mere placement of an RUO or IUO label on an IVD product does not render the device exempt from otherwise applicable clearance, approval, or other requirements." FDA may decide a product has a different intended use "based on other evidence, including how the device is marketed."
3. Intended use is judged from the whole picture
FDA looks at the "objective intent" of the people responsible for labeling a product, judged from the "totality of the circumstances." The guidance lists examples of evidence that can conflict with an RUO label, including statements in labeling, advertising or promotion, product names and descriptors, the kind of customers a company targets, and certain kinds of specialized support. It also says a user "certification program," where buyers promise to use a product only for research, is one factor to consider, but that such a program alone "would not relieve manufacturers from their responsibilities."
The general rule behind it
This "intended use" idea isn't limited to diagnostics. FDA's general definition for drugs, 21 CFR 201.128, says intended use refers to "the objective intent of the persons legally responsible for the labeling of an article," and that this intent may be shown by their expressions, the design or composition of the article, or "the circumstances surrounding the distribution of the article," for example "labeling claims, advertising matter, or oral or written statements" (21 CFR 201.128).
Put simply: what a product is "for" is judged by what the seller says and does, not only by the small print on the label.
What RUO should mean in practice for a supplier
If intended use is judged from everything a supplier says and does, then "research use only" has to run through the whole business, not sit in a footer. In practice that means:
- Labeling and descriptions that stay in the lab. Product pages describe identity, purity, form, storage and documentation. They don't describe what a material might do outside an experiment.
- No outcome promises. Marketing that promises outcomes of any kind outside the laboratory contradicts an RUO label.
- Research-appropriate support only. Help with documentation, lot records, storage and shipping is consistent with research supply. Advice that goes beyond laboratory handling isn't.
- Consistent messaging everywhere. Social posts, emails, affiliate and creator content, and customer-service replies all count as "circumstances surrounding distribution." A compliant product page doesn't cancel out a non-compliant post.
- Buyer acknowledgement as one layer, not the whole defense. A checkout acknowledgement is useful, but FDA's guidance is clear that it isn't enough by itself.
What RUO means in practice for a laboratory buyer
For the lab, an RUO label is a statement about the material's intended purpose and its documentation. It tells you:
- the material is supplied for laboratory research;
- it has not been approved, cleared or licensed by FDA for any other purpose;
- the supplier is responsible for describing it accurately (identity, purity, form, lot), and you are responsible for using it within your research program and your institution's rules.
It does not tell you the material is high quality. RUO is a statement of purpose, not a quality grade. Quality comes from documentation: a lot-specific certificate of analysis with identity by mass spectrometry, HPLC purity with a chromatogram, and a named laboratory and date. Our guide to what "third-party tested" should mean covers how to check that. Related reading: What "Third-Party Tested" Should Mean for a Research Peptide (and How to Check It).
RUO, IUO and the words around them
A few related labels come up often, and it helps to keep them apart:
| Label | What it signals |
|---|---|
| For Research Use Only (RUO) | Supplied for laboratory research; in the regulation's own words for diagnostic products, "not for use in diagnostic procedures" |
| For Investigational Use Only (IUO) | A later development phase, for product testing before full commercial marketing; the regulation's statement adds that "performance characteristics of this product have not been established" |
| "Laboratory grade" / "reagent grade" | Quality descriptors used by suppliers. They say nothing about intended use on their own |
The practical point is that labels work together with conduct. A label states a purpose. Everything else a supplier does either supports that purpose or undercuts it.
Common misunderstandings
- "An RUO label makes anything legal to sell." No. FDA has said the label alone doesn't exempt a product, and intended use is judged from the full picture.
- "RUO is a quality standard." No. It says what a material is for, not how pure it is.
- "A disclaimer in the footer is enough." Not if other statements by the seller point to a different use.
- "Only the product page matters." Advertising, social media, emails and representatives' statements all count as evidence of intent.
How Seratide applies it
Seratide sells research peptides for laboratory research use only, and we try to make that true in everything we publish, not just in a footer. Our product pages describe compound, strength, form, storage and lot documentation. Every vial carries a lot number linked to a record on the Lot lookup page (today these are clearly labeled layout samples showing the format). Our full research-use terms are on the Research Use Only policy page, and who operates Seratide is on our About page.
Sources
All sources were opened and read on 2026-09-29.
- 21 CFR 809.10, Labeling for in vitro diagnostic products, paragraph (c)(2)(i). eCFR, up to date as of 25 September 2026. https://www.ecfr.gov/current/title-21/chapter-I/subchapter-H/part-809/subpart-B/section-809.10
- US Food and Drug Administration. Distribution of In Vitro Diagnostic Products Labeled for Research Use Only or Investigational Use Only: Guidance for Industry and FDA Staff. Issued 25 November 2013. Docket FDA-2011-D-0305. https://www.fda.gov/media/87374/download
- 21 CFR 201.128, Meaning of "intended uses" (as amended 86 FR 41401, 2 August 2021). https://www.law.cornell.edu/cfr/text/21/201.128
For laboratory research use only.